Healthcare & Pharma
In this category, an inaccurate AI answer is a regulatory problem.
Publish medically reviewed, compliance-gated content at scale — and make sure AI engines describe your therapies and indications accurately.
What we hear
- Medical and legal review turns a two-week piece into a two-month one.
- YMYL scrutiny means weak E-E-A-T signals cap your ceiling permanently.
- Models describe indications, contraindications or dosing incorrectly.
The plays that work here
- 01
Review gates built into the workflow
Medical reviewer, legal and regulatory sign-off are stages in the pipeline with timestamps and audit trails, not emails outside the system.
- 02
E-E-A-T signals that hold up
Credentialed author profiles, reviewer attribution, citation to primary literature, and explicit review dates on every page.
- 03
Accuracy monitoring across engines
Track how the models describe your therapies and get alerted the moment an answer drifts from the label.
- 04
Claim-safe generation
Content generation constrained to approved claim libraries, so nothing reaches review that could never have been published anyway.
“Compliance was never going to be negotiable. Having the medical review gate inside the tool — with an audit trail our regulatory team accepts — is the only reason this scaled at all.”
Also relevant
Other categories
If your business straddles two of these, the overlap is usually where the fastest wins are.
Ready to see this on your healthcare & pharma site?
A strategist who works with healthcare & pharma accounts will run a live baseline and show you the first three things they would fix.
7-day trial · No card required · Cancel anytime